secwatch / observer
8-K filed September 6, 2023, 7:59 PM ET ticker PHR CIK 0001412408
earnings confidence high sentiment neutral materiality 0.75

Phreesia reports Q2 FY2024 revenue $85.8M (+26% YoY); raises EBITDA outlook

Phreesia, Inc.

2024-Q2 EPS reported -$1.39 revenue$169,675,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Phreesia, Inc. reported fiscal quarter ended July 31, 2023 results: revenue $85.8 million, net income Net loss was $36.8 million. Guidance reaffirmed.

Period
fiscal quarter ended July 31, 2023
Revenue
$85.8 million
Net income
Net loss was $36.8 million
Guidance
reaffirmed
Result
reported results
Exact text from the filing
relations website at ir.phreesia.com to view the Company's Q2 Fiscal Year 2024 Stakeholder Letter. Fiscal Second Quarter Ended July 31, 2023 Highlights • Total revenue was $85.8 million in the quarter as compared to $67.9 million in the same period in the prior year, an increase of 26%. • Average number of healthcare services clients ("AHSCs") was 3,445 in the
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Phreesia, Inc. updated its fiscal year 2024 ending January 31, 2024 guidance (reaffirmed).

Period
fiscal year 2024 ending January 31, 2024
Guidance
reaffirmed
Result
guidance update
Exact text from the filing
We are maintaining our revenue outlook for the full fiscal year 2024 ending January 31, 2024 at between $353 million and $356 million
View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

Phreesia, Inc. filing history →

Source: SEC EDGAR
accession 0001412408-23-000123
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.